Skip to main content

Breast Cancer Research and Treatment

Ausgabe 3/2016

Inhalt (19 Artikel)

Review

Cost–utility analyses of drug therapies in breast cancer: a systematic review

Virginie Nerich, Sopany Saing, Eva Maria Gamper, Georg Kemmler, Franck Daval, Xavier Pivot, Bernhard Holzner

Preclinical study

Association study confirms two susceptibility loci for breast cancer in Chinese Han women

Minggui Xu, Yihui Xu, Mengyun Chen, Yang li, Wei li, Jun Zhu, Mingjun Zhang, Zhendong Chen, Xuejun Zhang, Jianjun liu, Bo Zhang

Preclinical study

Phosphorylation of LSD1 at Ser112 is crucial for its function in induction of EMT and metastasis in breast cancer

Jingxin Feng, Guiying Xu, Jiwei Liu, Na Zhang, Lili Li, Jiafei Ji, Jianchao Zhang, Lian Zhang, Guannan Wang, Xiuli Wang, Jiang Tan, Baiqu Huang, Jun Lu, Yu Zhang

Open Access Preclinical study

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers

Dena A. J. Ahmad, Ola H. Negm, M. Layth Alabdullah, Sameer Mirza, Mohamed R. Hamed, Vimla Band, Andrew R. Green, Ian O. Ellis, Emad A. Rakha

Preclinical Study

Exercise regulates breast cancer cell viability: systemic training adaptations versus acute exercise responses

Christine Dethlefsen, Christian Lillelund, Julie Midtgaard, Christina Andersen, Bente Klarlund Pedersen, Jesper Frank Christensen, Pernille Hojman

Clinical trial

Genomic profiling of breast cancer in African-American women using MammaPrint

Raquel A. Nunes, Lynette Wray, Mihriye Mete, Pia Herbolsheimer, Karen L. Smith, Lana Bijelic, Marc E. Boisvert, Sandra M. Swain

Clinical trial

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society

Jai Min Ryu, Hyouk Jin Lee, Tae in Yoon, Eun Sook Lee, Soo Jung Lee, Jin Hyang Jung, Byung Joo Chae, Seok Jin Nam, Jeong Eon Lee, Se Kyung Lee, Soo Youn Bae, Jonghan Yu, Seok Won Kim

Clinical trial

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

A. S. Hamy, I. Bieche, J. Lehmann-Che, V. Scott, Ph. Bertheau, J. M. Guinebretière, M. C. Matthieu, B. Sigal-Zafrani, O. Tembo, M. Marty, B. Asselain, F. Spyratos, P. de Cremoux

Epidemiology

Breast cancer risk prediction using a clinical risk model and polygenic risk score

Yiwey Shieh, Donglei Hu, Lin Ma, Scott Huntsman, Charlotte C. Gard, Jessica W. T. Leung, Jeffrey A. Tice, Celine M. Vachon, Steven R. Cummings, Karla Kerlikowske, Elad Ziv

Epidemiology

Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors

Laura C. Pinheiro, Cleo A. Samuel, Katherine E. Reeder-Hayes, Stephanie B. Wheeler, Andrew F. Olshan, Bryce B. Reeve

Epidemiology

A prospective study of endometriosis and risk of benign breast disease

Leslie V. Farland, Rulla M. Tamimi, A. Heather Eliassen, Donna Spiegelman, Laura C. Collins, Stuart J. Schnitt, Stacey A. Missmer

Open Access Epidemiology

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women

Lotte E. Elshof, Michael Schaapveld, Marjanka K. Schmidt, Emiel J. Rutgers, Flora E. van Leeuwen, Jelle Wesseling

Brief Report

Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH

Karl Hackmann, Franziska Kuhlee, Elitza Betcheva-Krajcir, Anne-Karin Kahlert, Luisa Mackenroth, Barbara Klink, Nataliya Di Donato, Andreas Tzschach, Karin Kast, Pauline Wimberger, Evelin Schrock, Andreas Rump

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.